Case study: RMM to reduce plate counts
Posted: 30 July 2021 | Mettler-Toledo Thornton | No comments yet
See how a pharma company maintained product quality and reduced risk by using an RMM analyser, while also meeting their goal of reducing plate counts by 25 percent.
Remaining competitive in a global marketplace is a challenge for biotech and pharma companies, as they must focus on optimising costs while improving efficiency and mitigating risk. This case study explains how a Chinese pharma company improved its water system process control.
Related content from this organisation
Analytical techniques, Biologics, Biopharmaceuticals, Bioprocessing, Data integrity, Environmental Monitoring, Manufacturing, Microbiology, QA/QC, Regulation & Legislation, Research & Development (R&D)